AGL Agilon Health, Inc.
Healthcare$85.27-1.30%ClosedMarket Cap: $1.42B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.90
P/S
0.25
EV/EBITDA
-3.52
DCF Value
$-1,112.55
FCF Yield
-5.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-2.7%
Operating Margin
-6.8%
Net Margin
-6.4%
ROE
-146.0%
ROA
-24.8%
ROIC
-158.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.42B | 4.1% | $10.1M | $30.0M | $— | — |
| Q4 null | $1.57B | -6.2% | $-155.8M | $-188.9M | $— | — |
| FY null | $5.93B | -3.2% | $-421.1M | $-405.3M | $— | — |
| Q3 null | $1.44B | -4.7% | $-131.3M | $-110.2M | $— | — |
| Q2 null | $1.39B | -3.8% | $-116.0M | $-104.4M | $— | — |
| Q1 null | $1.53B | 3.3% | $-22.1M | $12.1M | $— | — |
| Q4 null | $1.52B | -2.5% | $-108.1M | $-105.8M | $— | — |
| FY null | $6.06B | 0.1% | $-292.1M | $-260.2M | $— | — |
| Q3 null | $1.45B | -4.4% | $-133.5M | $-117.6M | $— | — |
| Q2 null | $1.48B | 2.2% | $-43.3M | $-30.7M | $— | — |
| Q1 null | $1.60B | 4.7% | $-7.2M | $-6.1M | $— | — |
| Q4 2023 | $815.5M | -11.7% | $-159.6M | $-230.4M | $-14.00 | — |